Eyestem: Eyestem's promising pipeline of products catches the eye of traditional pharma companies
The company's potential therapy for dry age-related macular degeneration awaits regulatory approvals in India for a trial in humans
Read full article »
Eyestem is an India-based biotechnology company that develops and commercializes cell-based therapies for the treatment of dry age-related macular degeneration disorders.
Read more